Skip to content

Albumin Procedure BCP

by Sandare Chemical Co., Inc. 510(k)

Active United States

510(k) K832632

Overview

Albumin Procedure BCP is a bromcresol purple dye-binding assay for albumin, classified under Clinical Chemistry. It is an in vitro diagnostic device used for the quantitative determination of albumin in serum or plasma samples.

The device is supplied as a reagent system for laboratory use, requiring appropriate storage conditions as specified by the manufacturer. It is a traditional 510(k) cleared product with product code CJW and regulation number 862.1035, intended for use in clinical chemistry laboratories.

AI-generated from registry data, 25 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK832632 Date12 Sep 1983ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
CJW
Device Class
Class II
Regulation
21 CFR Part 862.1035
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Sandare Chemical Co., Inc.

See all devices from Sandare Chemical Co., Inc. →

Questions

  • What is the ALBUMIN PROCEDURE BCP used for?

    The ALBUMIN PROCEDURE BCP is an in vitro diagnostic device used for the quantitative determination of albumin in serum or plasma samples, employing a bromcresol purple dye-binding assay method within clinical chemistry testing.

  • How is the ALBUMIN PROCEDURE BCP supplied and stored?

    The device is supplied as a reagent system for laboratory use and requires appropriate storage conditions as specified by the manufacturer to maintain stability and performance.

  • Is the ALBUMIN PROCEDURE BCP a single-use or reusable reagent system?

    As a traditional 510(k) cleared reagent system for quantitative albumin testing, the ALBUMIN PROCEDURE BCP is intended for single-use per test run in clinical chemistry laboratories, consistent with standard reagent consumption for such assays.

  • What regulatory pathway was used for the ALBUMIN PROCEDURE BCP?

    The ALBUMIN PROCEDURE BCP received clearance through the traditional 510(k) pathway, identified by k-number K832632, and is classified under product code CJW with regulation number 862.1035.